Established in 1991, Shanghai Dahua Pharmaceutical Co., Ltd (known as Dahua) is a trusted global leader in the production of safe and effective long-acting contraceptive implants.

We are committed to ensuring the quality, safety and effectiveness of our products.

We are designated by the National Health and Family Planning Commission of the People's Republic of China (NHFPC) and the China Food and Drug Administration (CFDA) as an approved manufacturer of contraceptive products.

Since 1996, we have been manufacturing Sino-implant (II), a highly effective, high quality, two-rod contraceptive implant distributed with a CE-marked disposable trocar. Registered in over 20 countries worldwide, Sino-implant (II) is sold under the global brand Levoplant as well as other trade names, such as Femplant, Trust and Zarin, in certain territories.

Our full-scale manufacturing facility is located east of Shanghai and includes production lines, climate-controlled warehousing and a quality control lab. We received Good Manufacturing Practice (GMP) certification from the CFDA in 2004, and our certification has been continuously renewed since then through re-inspections in 2009 and 2013. Our facility was also deemed to be in compliance with World Health Organization (WHO) GMP first in 2013 and then again in 2015, following re-inspection.

A number of other independent international organizations and national drug regulatory authorities have evaluated our products and facility, confirming that we meet international standards

Please contact us with any questions.

Dahua is an affiliated company of Bright Food (Group) Co., Ltd. Bright Food is a comprehensive food industry group with an operating income of more than USD 18 billion in 2014. It was named one of the “Top Ten Most Noteworthy Chinese Companies on the International Stage in 2015” by US Forbes Magazine. Please visit their website for more details: www.brightfood.com

沪公网安备 31023002000140号